Vizgen

Vizgen is a life sciences technology company that develops advanced spatial biology and multi-omics platforms to help scientists map and understand gene and protein expression within intact tissues at single-cell resolution. Its core technologies include MERFISH 2.0, a high-plex spatial transcriptomics method that enables detailed visualization of thousands of RNA molecules while preserving spatial context, and the MERSCOPE imaging platforms that support comprehensive spatial genomics experiments with high sensitivity and reproducibility. Complementing transcriptomic data, Vizgen’s InSituPlex® multiplex immunofluorescence proteomics assays and STARVUE™ AI-driven image analysis tools enable quantitative protein detection and the integration of RNA-protein insights, empowering researchers to explore complex biological systems, such as tumor microenvironments, immune landscapes, and tissue architecture. Vizgen’s platforms are designed to accelerate breakthroughs in understanding disease mechanisms and advancing drug discovery by enabling unprecedented views into cellular organization and molecular interactions within tissues.

Domain

vizgen.com

Employees

101-250

Last Funding

$48.0M

Founded

2019

No technologies detected yet for this company.

Frequently Asked Questions

What technologies does Vizgen use?+

We have not yet detected technologies for Vizgen.

What industry is Vizgen in?+

Vizgen operates in the Biotechnology industry.

Where is Vizgen based?+

Vizgen is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026